MDXH Competitors & Alternatives
Compare MDxHealth SA ADR with similar stocks in the same industry
Diagnostics & Research
MDXH
Main Stock$2.00
Tradestie Score
52
Market Cap
$231.40M
Revenue Growth
0.2%
Analyst Upside
+270.0%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OPK
Opko Health Inc.
|
$1.14
|
$1.23B | - | 54 | Compare |
|
NEO
NeoGenomics, Inc.
|
$8.96
|
$1.13B | - | 57 | Compare |
|
CDNA
CareDx, Inc.
|
$21.82
|
$798.40M | - | 63 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$19.83
|
$667.77M | - | 45 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$5.98
|
$612.76M | - | 57 | Compare |
|
SOPH
SOPHiA GENETICS SA Ordinary Shares
|
$5.15
|
$300.73M | - | 59 | Compare |
|
MOLN
Molecular Partners AG American Depositary Shares
|
$4.10
|
$138.88M | - | 51 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$1.88
|
$112.28M | - | 54 | Compare |
|
LUCD
Lucid Diagnostics Inc. Common Stock
|
$1.03
|
$103.93M | - | 49 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$15.32
|
$61.36M | - | 53 | Compare |
More MDXH Analysis
Data updated: May 09, 2026 | Industry: Diagnostics & Research (SIC 8071)
38 stocks in this industry